Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Takara Bio Inc. ( (JP:4974) ) has issued an update.
Takara Bio Inc. has moved to set April 14, 2026, as the record date for shareholders eligible to vote at an extraordinary general meeting planned for late May. The notice will be published electronically on the company’s website on March 30, 2026, aligning with Japanese corporate governance requirements for shareholder notifications.
The extraordinary meeting is being prepared in connection with a tender offer for Takara Bio shares by its parent company, Takara Holdings, which aims to make the tender offeror the sole shareholder. Depending on the final ownership ratio achieved through the tender offer, Takara Holdings expects either to use the special controlling shareholder squeeze-out procedure or to seek approval at the meeting for a share consolidation and related amendments, steps that could ultimately lead to the delisting and full privatization of Takara Bio and significantly affect minority shareholders’ positions.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen1162.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc., listed on the Tokyo Stock Exchange Prime section, operates in the biotechnology and life sciences sector. The company focuses on research tools and technologies, as well as related products and services that support advanced biological and medical research in Japan and global markets.
Average Trading Volume: 620,253
Technical Sentiment Signal: Hold
Current Market Cap: Yen138.1B
Find detailed analytics on 4974 stock on TipRanks’ Stock Analysis page.